Table 1.
Prospective trials of RIC allo-HSCT for relapsed FL
CALGB indicates Cancer and Leukemia Group B; GELTAMO, Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea; FHCRC, Fred Hutchinson Cancer Research Center; flu: fludarabine; Cy: cyclophosphamide; alem, alemtuzumab; mel, melphalan; MRD, matched related donor; URD, unrelated donor; DFS, disease-free survival; Y90, Y90-ibritumomab tiuxetan.
